Vegetal Silica (Horsetail).

Vegetal silica is plant-sourced silicon dioxide, so it feeds the same orthosilicic acid pool as any other silica source. Stacking both raises total silicon intake rather than adding a second mechanism.

Silicon is the element delivered by vegetal silica once it hydrolyses to orthosilicic acid in the gut. Any silicon source and vegetal silica overlap directly.

Prolyl and lysyl hydroxylase need ascorbate to build stable collagen triple helices, and silicon is associated with connective tissue matrix formation. Silicon without ascorbate leaves the hydroxylation step short of its cofactor.

Collagen peptides supply glycine and proline building blocks, and silicon is concentrated in connective tissue and associated with collagen matrix formation. The pairing supplies substrate alongside the trace element found in that tissue.

Thiaminase in horsetail splits the thiamine molecule at its methylene bridge, destroying the vitamin. The enzyme is heat labile, so processing matters, and reputable extracts are specified as thiaminase-free. Where raw plant material is used the antagonism is real and works against thiamine status rather than with it. This is the clearest interaction on the ingredient and it runs in the negative direction.

Silicon is associated with the early stages of collagen matrix formation on which mineral is laid down, and boron is studied for its effect on mineral handling and on steroid hormone metabolism. The two occupy the same formulation slot in structural-support blends. The evidence for each is separate and the combination has not been measured. Read it as formulation convention with a plausible shared target tissue.

Bone is a mineral phase deposited on an organic collagen scaffold. Silicon has been linked in observational and animal work to that scaffold's formation, while calcium supplies the mineral. The sequence is why the two are put together. The link between dietary silicon and bone mineral density in people comes from observational cohorts, which show association and not cause.

Calcitriol, the active form of vitamin D, drives intestinal calcium absorption through calbindin and the TRPV6 channel, which is settled physiology. Silicon is on the matrix side of the same tissue rather than the mineral side. Combining them addresses two different steps of normal bone maintenance. The vitamin D part is established; the silicon part is not.

Vitamin K is the cofactor for gamma-glutamyl carboxylase, which carboxylates osteocalcin so it can bind calcium into the bone matrix. Silicon's contribution is described at the collagen scaffold stage. The two act at different points of normal bone turnover, which is why they share formulations. The carboxylation step is textbook; the silicon step is not at that level.

Xylosyltransferase and the galactosyltransferases that assemble proteoglycan linkage regions require manganese. Silicon has been described in connective tissue as associated with the glycosaminoglycan fraction. Both therefore relate to the same ground substance, one as a settled enzyme cofactor and one by association. The manganese half is established biochemistry.

Lysyl oxidase needs copper at its active site to oxidise lysine residues and form the cross-links that give collagen and elastin their tensile strength. Silicon is associated with the same connective tissue compartment. Pairing a mineral silica source with copper covers a settled cross-linking step alongside an associative one. Only the copper relationship is established.

Zinc sits in the catalytic site of matrix metalloproteinases, which handle the remodelling side of connective tissue turnover, and it is also needed for normal protein synthesis. Formulations combining structural minerals should account for zinc competing with copper and iron for divalent transporters. The cofactor role is settled; the competition at absorption is settled as well. Both directions are worth stating.

Collagen cross-linking begins with lysine and hydroxylysine residues in the triple helix, which lysyl oxidase converts to aldehydes that then condense. Lysine is an indispensable amino acid, so the residues have to come from the diet. Silica sources are combined with lysine in connective tissue formulas on that reasoning. The lysine chemistry is textbook; the silicon contribution to it is not.

Prolyl hydroxylase converts proline residues in the nascent collagen chain to hydroxyproline, a step that requires vitamin C, iron and 2-oxoglutarate and that stabilises the triple helix. Proline supply feeds that structure. Silica sources are combined with proline for the same connective tissue reason. Only the proline and hydroxylation chemistry is established.

Hyaluronan is a glycosaminoglycan that holds water in the extracellular matrix, and silicon has been reported in connective tissue in association with the glycosaminoglycan fraction. The combination is formulation convention in skin and joint blends. No study of the pair grounds the row. It is an overlap of target tissue, not a demonstrated interaction.

Methylsulfonylmethane supplies sulfur and horsetail supplies silicon, and the two are combined in hair, skin, nail and joint blends. There is no shared enzymatic step between them. The row records a formulation convention. Neither compound's role is established at the level the pairing implies.

Biotin is the covalently bound cofactor for the four human carboxylases, including acetyl-CoA carboxylase in fatty acid synthesis, which is settled biochemistry. It is combined with silica sources in keratin-support formulas by convention rather than by a shared pathway. The carboxylase role is established; the combination has not been tested. The additive label refers to formulation, not to a measured effect.

Polyphenolic galloyl groups bind ferric iron in the intestinal lumen and form complexes that the DMT1 transporter cannot take up. Plant extracts carrying a tannin fraction therefore reduce non-heme iron absorption when taken in the same meal. Separating the two by a couple of hours is the standard way around it. This is settled nutrient interaction pharmacology.

An increase in urine volume increases obligatory electrolyte loss, potassium included. Horsetail's traditional use is as an aquaretic, and monograph-level sources describe it that way. Anyone already using something that increases urine output should account for the additive direction. The magnitude has not been quantified here.

About half of body magnesium sits in bone, where it is part of the mineral phase and influences hydroxyapatite crystal size. Silicon is described at the collagen matrix stage of the same tissue. The two are combined for that reason. The magnesium role in bone is established; the pairing itself has not been tested.

Strontium is chemically similar to calcium and exchanges into the surface of the bone mineral phase, which also inflates bone density readings taken by X-ray absorptiometry. Silicon is on the organic matrix side. Combining them mixes a matrix-associated element with a mineral-phase substitute. Density readings taken after strontium use are a measurement artefact to be aware of, not evidence of added bone.